Literature DB >> 10585356

New method for determining cystine in leukocytes and fibroblasts.

A de Graaf-Hess1, F Trijbels, H Blom.   

Abstract

BACKGROUND: Cystinosis is a rare inborn error of cystine transport, leading to accumulation of cystine in the lysosomes. To diagnose cystinosis and monitor treatment with cysteamine, adequate measurements of cystine concentrations in leukocytes and cultured fibroblasts are required.
METHODS: Cells were sonicated in the presence of excess N-ethylmaleimide to prevent oxidation of cysteine to cystine and disulfide exchange reactions of cystine with available sulfhydryl moieties. Cystine was measured as cysteine after reduction with sodium borohydride and derivatization with monobromobimane, followed by separation with automated HPLC and fluorescence detection.
RESULTS: The assay was linear to 200 micromol/L cysteine. Within-run and day-to-day (total) imprecision (CV) was <5%, and the detection limit was 0.3 micromol/L. Added cysteine, up to 200 micromol/L, was completely removed, and recovery of added cystine was 69-86%. Cystine was stable for at least 2 months in leukocytes frozen in liquid nitrogen and stored at -80 degrees C
CONCLUSIONS: Oxidation of cysteine to cystine and disulfide exchange reactions of cystine with sulfhydryl moieties are prevented by N-ethylmaleimide. The detection limit for the determination of cystine is adequate to measure cystine in leukocytes and cultured fibroblasts for diagnosis of cystinosis and monitoring treatment with cysteamine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585356

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Altered mTOR signalling in nephropathic cystinosis.

Authors:  Ekaterina A Ivanova; Lambertus P van den Heuvel; Mohamed A Elmonem; Humbert De Smedt; Ludwig Missiaen; Anna Pastore; Djalila Mekahli; Greet Bultynck; Elena N Levtchenko
Journal:  J Inherit Metab Dis       Date:  2016-02-24       Impact factor: 4.982

2.  Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.

Authors:  Elena N Levtchenko; Carin M van Dael; Addy C de Graaf-Hess; Martijn J G Wilmer; Lambertus P van den Heuvel; Leo A Monnens; Henk J Blom
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.

Authors:  Koenraad R P Veys; Mohamed A Elmonem; Maria Van Dyck; Mirian C Janssen; Elisabeth A M Cornelissen; Katharina Hohenfellner; Giusi Prencipe; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  J Am Soc Nephrol       Date:  2020-04-09       Impact factor: 10.121

4.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

5.  Targeted albumin-based nanoparticles for delivery of amphipathic drugs.

Authors:  Rongzuo Xu; Michael Fisher; R L Juliano
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

6.  Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.

Authors:  Emma Hector; Donald Cairns; G Michael Wall
Journal:  Orphanet J Rare Dis       Date:  2022-06-16       Impact factor: 4.303

7.  Listeria monocytogenes CtaP is a multifunctional cysteine transport-associated protein required for bacterial pathogenesis.

Authors:  Bobbi Xayarath; Hélène Marquis; Gary C Port; Nancy E Freitag
Journal:  Mol Microbiol       Date:  2009-10-08       Impact factor: 3.501

Review 8.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 9.  Cystinosis: practical tools for diagnosis and treatment.

Authors:  Martijn J Wilmer; Joost P Schoeber; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

10.  Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis.

Authors:  Mohamed A Elmonem; Samuel H Makar; Lambertus van den Heuvel; Hanan Abdelaziz; Safaa M Abdelrahman; Xavier Bossuyt; Mirian C Janssen; Elisabeth Am Cornelissen; Dirk J Lefeber; Leo Ab Joosten; Marwa M Nabhan; Fanny O Arcolino; Fayza A Hassan; Héloïse P Gaide Chevronnay; Neveen A Soliman; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2014-11-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.